XML 48 R29.htm IDEA: XBRL DOCUMENT v3.25.1

Other Current Assets (Tables)

12 Months Ended

Dec. 31, 2024

Deferred Costs, Capitalized, Prepaid, and Other Assets Disclosure [Abstract]

Schedule of Other Current Assets

Other current assets consisted of the following at December 31:

   Schedule of Other Current Assets

		2024				2023
Current:
Prepaid clinical trial costs		$	6,768,668			$	8,763,150
Miscellaneous receivable			1,600,621				805,882
Directors & officers’ insurance			256,629				157,453
Other			841,329				281,364
Total		$	9,467,247			$	10,007,849

X

- References

No definition available.

+ Details

Name:	us-gaap_DeferredCostsCapitalizedPrepaidAndOtherAssetsDisclosureAbstract
Namespace Prefix:	us-gaap_
Data Type:	xbrli:stringItemType
Balance Type:	na
Period Type:	duration

X

- Definition

Tabular disclosure of the carrying amounts of other current assets.

+ References

No definition available.

+ Details

Name:	us-gaap_ScheduleOfOtherCurrentAssetsTableTextBlock
Namespace Prefix:	us-gaap_
Data Type:	dtr-types:textBlockItemType
Balance Type:	na
Period Type:	duration